Cardiac explant-derived cells are regulated by Notch-modulated mesenchymal transition.
Progenitor cell therapy is emerging as a novel treatment for heart failure. However the molecular mechanisms regulating the generation of cardiac progenitor cells is not fully understood. We hypothesized that cardiac progenitor cells are generated from cardiac explant via a process similar to epithe...
Main Authors: | Liudmila Zakharova, Hikmet Nural-Guvener, Mohamed A Gaballa |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3360598?pdf=render |
Similar Items
-
Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure
by: Hikmet Nural-Guvener, et al.
Published: (2015-05-01) -
Bevacizumab modulates retinal pigment epithelial-to-mesenchymal transition via regulating Notch signaling
by: Jing-Jing Zhang, et al.
Published: (2015-04-01) -
Lineage tracing of cardiac explant derived cells.
by: Lincoln T Shenje, et al.
Published: (2008-04-01) -
Explanting Is an Ex Vivo Model of Renal Epithelial-Mesenchymal Transition
by: Catherine E. Winbanks, et al.
Published: (2011-01-01) -
Relaxin inhibits cardiac fibrosis and endothelial–mesenchymal transition via the Notch pathway
by: Zhou X, et al.
Published: (2015-08-01)